ARCHIVES

NCI Director and Acting FDA Commissioner Andrew von Eschenbach Endorses Rep. E. Clay Shaw In Tour of Florida Congressman’s District. Von Eschenbach Praises Shaw’s “Leadership” In Seeking Funding For Research, Support of 2015 Goal.

This article is from The Cancer Letter archive.

Vol. 32 No. 04 | February 3, 2006

Download PDF Visit The Full Archive

Related Articles

In Legal Brawl, UPenn and Abramson Institute Allege Former Director Craig Thompson “Absconded” With Inventions

March 9, 2012

NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification

April 10, 1981

In Brief: NCI Figure Left unchanged By Carter; Pay Raise Puts further Squeeze On Institute Budget

March 4, 1977

Also in this 8-page issue: NCI contract will keep Cancer Genetics Network database alive, but center grants will not be recompeted.

July 23, 2004

HHS To Determine Feasibility Of CHOP Evaluation

July 24, 1981

Letter: No Intent To Link Flags With NSABP Inquiry, ORI’s Bivens Writes

March 10, 1995